|
NYVAC-PRV- gII/ gp50 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004778
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- GII
gene engineering:
- Type: Recombinant vector construction
- Description: A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 (Brockmeier and Mengeling, 1996).
- Detailed Gene Information: Click Here.
- gp50
gene engineering:
- Type: Recombinant vector construction
- Description: A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 (Brockmeier and Mengeling, 1996).
- Detailed Gene Information: Click Here.
- Preparation: (Brockmeier and Mengeling, 1996) A NYVAC vaccinia vector containing genes for PRV gII and gp50 .
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Brockmeier and Mengeling, 1996: Brockmeier SL, Mengeling WL. Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 1996; 60(4); 315-317. [PubMed: 8904669].
|
|
Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine |
| Vaccine Information |
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Raccoon
- glycoprotein G
gene engineering:
- Type: Gene mutation
- Description: This glycoprotein E/G/UL23 mutant is from Suid herpesvirus 1 (Weigel et al., 2003).
- Detailed Gene Information: Click Here.
- glycoprotein E
gene engineering:
- Type: Gene mutation
- Description: This glycoprotein E/G/UL23 mutant is from Suid herpesvirus 1 (Weigel et al., 2003).
- Detailed Gene Information: Click Here.
- UL23
gene engineering:
- Type: Gene mutation
- Description: This glycoprotein E/G/UL23 mutant is from Suid herpesvirus 1 (Weigel et al., 2003).
- Detailed Gene Information: Click Here.
- Immunization Route: intranasal immunization
|
| References |
Weigel et al., 2003: Weigel RM, Hahn EC, Scherba G. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines. Veterinary microbiology. 2003; 92(1-2); 19-24. [PubMed: 12488067].
|
|
Pseudorabies virus gp50/gp63 mutant vaccine |
| Vaccine Information |
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Pig
- gp50
gene engineering:
- Type: Gene mutation
- Description: This gp50/gp63 mutant is from Suid herpesvirus 1 (Peeters et al., 1994).
- Detailed Gene Information: Click Here.
- gp63
gene engineering:
- Type: Gene mutation
- Description: This gp50/gp63 mutant is from Suid herpesvirus 1 (Peeters et al., 1994).
- Detailed Gene Information: Click Here.
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Peeters et al., 1994: Peeters B, Bouma A, de Bruin T, Moormann R, Gielkens A, Kimman T. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines. Vaccine. 1994; 12(4); 375-380. [PubMed: 8178562].
|
|
Pseudorabies virus UL50 mutant vaccine |
| Vaccine Information |
- Vaccine Ontology ID: VO_0002989
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Pig
- UL50
gene engineering:
- Type: Gene mutation
- Description: This UL50 mutant is from Suid herpesvirus 1 (Jöns et al., 1997).
- Detailed Gene Information: Click Here.
- Immunization Route: intranasal immunization
|
| References |
Jöns et al., 1997: Jöns A, Gerdts V, Lange E, Kaden V, Mettenleiter TC. Attenuation of dUTPase-deficient pseudorabies virus for the natural host. Veterinary microbiology. 1997; 56(1-2); 47-54. [PubMed: 9228681].
|
|
Pseudorabies virus US3 mutant vaccine |
| Vaccine Information |
- Vaccine Ontology ID: VO_0002990
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Pig
- US3
gene engineering:
- Type: Gene mutation
- Description: This US3 mutant is from Suid herpesvirus 1 (Kimman et al., 1994).
- Detailed Gene Information: Click Here.
- Immunization Route: intranasal immunization
|
| References |
Kimman et al., 1994: Kimman TG, De Wind N, De Bruin T, de Visser Y, Voermans J. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology. 1994; 205(2); 511-518. [PubMed: 7975253].
|
|
Psuedorabies virus glycoprotein M mutant vaccine |
| Vaccine Information |
- Vaccine Ontology ID: VO_0002985
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Pig
- glycoprotein M
gene engineering:
- Type: Gene mutation
- Description: This glycoprotein M mutant is from Pseudorabies virus (Dijkstra et al., 1997).
- Detailed Gene Information: Click Here.
- Immunization Route: intranasal immunization
|
| References |
Dijkstra et al., 1997: Dijkstra JM, Gerdts V, Klupp BG, Mettenleiter TC. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host. The Journal of general virology. 1997; 78 ( Pt 9); 2147-2151. [PubMed: 9292000].
|
